EDGEMOND JAMES bought UTHR
March 15, 2026 · Form 4 insider transaction
EDGEMOND JAMES bought 9,098 shares of United Therapeutics Corporation, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,098
Price
N/A
Total value
N/A
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 15, 2026
Filing dateMarch 17, 2026
Shares owned after27,662
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.